Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 18 | 4 | CHEMISTRY, ANALYTICAL//TOXICOLOGY//ENVIRONMENTAL SCIENCES | 697102 |
| 305 | 3 | NSAIDS//TOXIC EPIDERMAL NECROLYSIS//NON STEROIDAL ANTI INFLAMMATORY DRUGS | 41294 |
| 736 | 2 | NSAIDS//NON STEROIDAL ANTI INFLAMMATORY DRUGS//DICLOFENAC | 13004 |
| 25886 | 1 | OXAPROZIN//4 5 DIARYLOXAZOLE//4 ACETAMIDOPHENYL 2 5 P TOLUYL 1 METHYLPYRROLEACETATE PHARMACOKINETICS | 290 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | OXAPROZIN | authKW | 521641 | 4% | 40% | 12 |
| 2 | 4 5 DIARYLOXAZOLE | authKW | 108678 | 0% | 100% | 1 |
| 3 | 4 ACETAMIDOPHENYL 2 5 P TOLUYL 1 METHYLPYRROLEACETATE PHARMACOKINETICS | authKW | 108678 | 0% | 100% | 1 |
| 4 | ACTIVE OSTEOARTHROSIS | authKW | 108678 | 0% | 100% | 1 |
| 5 | ADVERSE DRUG REACT SECT | address | 108678 | 0% | 100% | 1 |
| 6 | AU 8001 | authKW | 108678 | 0% | 100% | 1 |
| 7 | CARRAGEENIN ED50 | authKW | 108678 | 0% | 100% | 1 |
| 8 | CAS 2210 63 1 | authKW | 108678 | 0% | 100% | 1 |
| 9 | CAS 82239 77 8 | authKW | 108678 | 0% | 100% | 1 |
| 10 | CLINICAL THERAPEUTIC TRIAL | authKW | 108678 | 0% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 2610 | 55% | 0% | 159 |
| 2 | Rheumatology | 1234 | 12% | 0% | 35 |
| 3 | Chemistry, Medicinal | 385 | 11% | 0% | 33 |
| 4 | Medicine, General & Internal | 370 | 18% | 0% | 51 |
| 5 | Medicine, Research & Experimental | 207 | 11% | 0% | 32 |
| 6 | Toxicology | 154 | 8% | 0% | 22 |
| 7 | Chemistry, Multidisciplinary | 11 | 7% | 0% | 21 |
| 8 | Primary Health Care | 10 | 1% | 0% | 2 |
| 9 | Urology & Nephrology | 9 | 2% | 0% | 7 |
| 10 | Chemistry, Analytical | 5 | 3% | 0% | 10 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | ADVERSE DRUG REACT SECT | 108678 | 0% | 100% | 1 |
| 2 | FHWC | 108678 | 0% | 100% | 1 |
| 3 | MED CLIN 1 PHAGOCYTE PHYSIOPATHOL INFLAMMAT | 108678 | 0% | 100% | 1 |
| 4 | DRUG SAFETY EVALUAT BRANCH | 54338 | 0% | 50% | 1 |
| 5 | REHABIL MED CONROD | 54338 | 0% | 50% | 1 |
| 6 | ICTM ELECT | 27168 | 0% | 25% | 1 |
| 7 | CLIN LARGE ANIM SURG ORTHOPAED | 21734 | 0% | 20% | 1 |
| 8 | ACSRC | 12074 | 0% | 11% | 1 |
| 9 | FOOD SECTOR | 10866 | 0% | 10% | 1 |
| 10 | ADVERSE DRUG REACT UNIT | 7243 | 0% | 7% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | SEMINARS IN ARTHRITIS AND RHEUMATISM | 13687 | 6% | 1% | 16 |
| 2 | INVESTIGACION MEDICA INTERNACIONAL | 10984 | 1% | 3% | 3 |
| 3 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 9344 | 7% | 0% | 19 |
| 4 | PHARMATHERAPEUTICA | 8588 | 2% | 2% | 5 |
| 5 | RHEUMATOLOGY AND REHABILITATION | 7518 | 1% | 2% | 3 |
| 6 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 5093 | 5% | 0% | 15 |
| 7 | TGO-TIJDSCHRIFT VOOR GENEESMIDDELENONDERZOEK-JOURNAL OF DRUG RESEARCH-JDR | 4345 | 0% | 4% | 1 |
| 8 | DRUGS | 3715 | 5% | 0% | 14 |
| 9 | FOLIA PHARMACOLOGICA JAPONICA | 3551 | 2% | 1% | 6 |
| 10 | JOURNAL OF CLINICAL PHARMACOLOGY | 2823 | 4% | 0% | 12 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |